Safety and Efficacy of Single Agent Adjuvant Trastuzumab in Older Women With Early Stage Breast Cancer: A Phase II Trial
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 05 Jul 2017
At a glance
- Drugs Trastuzumab (Primary)
- Indications Early breast cancer
- Focus Adverse reactions
- 13 Jul 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 06 Jun 2011 Study design details presented at the 47th Annual Meeting of the American Society of Clinical Oncology.
- 02 Dec 2008 New trial record.